57 /100
HIGH RISK
Score updated May 30, 2026

SHFS — SHF Holdings, Inc. Dilution Risk Tracker

Track SHFS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SHFS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
55
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
47%
🔄 Reverse Split 55%
• 50-day avg $0.71 below $1 exchange minimum
🔁 Convertible Conversion 40%
• Significant convertible debt: 17% potential dilution
• Elevated convertible risk (60/100)
📉 Score Deterioration 40%
• Score rose 33 points recently (worsening)
🔔 Track SHFS — Get forecast alerts →

💹 Market Data

Market Cap$3.16M
Shares Outstanding6.46M
Float3.03M
Cash$6.78M
Debt$750.1K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 136.2% shares (2025Q4 vs prior)
14 institutional holders · 635.2K shares
#1 M3F, Inc. 308.0K shares
#2 Blue Owl Capital Holdings LP 151.8K shares
#3 T3 Companies, LLC 54.0K shares
+ 11 more holders Sign up free to view →

📉 Short Interest

Short Interest189.2K
Days to Cover1.0
% of Float6.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SHFS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SHFS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SHFS
📊 SHFS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SHFS Signal Convergence & Dark Pool Activity — StonkWhisper 📄 SHFS Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.